There was no correction between the circulating TB and UGT1A1 levels in NAFLD patients (ρ = 0.023, P = 0.767) and all subjects (ρ = 0.081, P = 0.383). Here, UGT1A1 is linked to metabolic dysfunction-associated steatotic liver disease.